3,250,000 Shares CoLucid Pharmaceuticals, Inc. Common Stock PURCHASE AGREEMENTPurchase Agreement • September 9th, 2016 • CoLucid Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
CoLucid Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 3,250,000 shares (the “Firm Shares”) of Common Stock, $0.001 par value per share (the “Common Stock”), of the Company. The Company has also granted to the several Underwriters an option to purchase up to 487,500 additional shares of Common Stock, on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement (this “Agreement”) are herein collectively called the “Securities.”
